Amiloidózis: vizsgálatok itt: Kanada
3 of 11 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseTaking peopleLong-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
- Where
- Vancouver
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07654855 - No phaseTaking peopleNon-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Where
- Halifax, London, Montreal, Rimouski, Toronto, Vancouver
- Életkor
- 18 év to 130 év
- People
- 1850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06465810 - No phaseBefejeződöttOverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- Where
- Calgary
- People
- 52 121 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06355934